Lazard Asset Management’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,693
| Closed | -$81K | – | 2330 |
|
|
2024
Q4 | $81K | Buy |
+22,693
| New | +$81K | ﹤0.01% | 1861 |
|
|
2024
Q1 | – | Sell |
-12,375
| Closed | -$69K | – | 2084 |
|
|
2023
Q4 | $69K | Buy |
+12,375
| New | +$69K | ﹤0.01% | 1803 |
|
|
2023
Q1 | – | Sell |
-4,685
| Closed | -$27K | – | 2316 |
|
|
2022
Q4 | $27K | Hold |
4,685
| – | – | ﹤0.01% | 2066 |
|
|
2022
Q3 | $41K | Buy |
+4,685
| New | +$41K | ﹤0.01% | 1877 |
|
|
2022
Q2 | – | Sell |
-3,834
| Closed | -$93K | – | 2397 |
|
|
2022
Q1 | $93K | Buy |
+3,834
| New | +$93K | ﹤0.01% | 1425 |
|